Combination Of Pituitrin Injection And Hysteroscopic Suction Curettage For Treating Type ? Cesarean Scar Pregnancy

Objective:To evaluate the efficacy and safety of pituitrin injection combined with hysteroscopy and suction curettage for Type ? cesarean scar pregnancy(CSP).Patients and Methods: From November 2016 to February 2019,31 patients(the experimental group)with Type ? cesarean scar pregnancy(CSP)in the First Affiliated Hospital of Nanjing Medical University were treated with pituitrin injection combined with hysteroscopic suction curettage,while 83 patients(the control group)with Type ? cesarean scar pregnancy were treated with uterine artery embolization(UAE)followed by suction curettage as first-line therapy.The clinical data were analyzed with statistics to compare the efficacy and safety between among the two groups.Results: The time of postoperative vaginal bleeding,postoperative hospitalization and the total hospitalization duration was shorter in the experimental group(P<0.05).The total hospitalization expenses and the occurrence rate of adverse reactions were lower in the experimental group than the control group(P<0.05).There was no significant difference in the treatment success rate,the average operative duration,the intraoperative blood loss,the time when serum ?-HCG return to the normal range and the recovery time of menstruation after hospital discharge between the two groups(P>0.05).Conclusion: For Type ? cesarean scar pregnancy,both uterine artery embolization(UAE)followed by suction curettage and pituitrin injection combined with hysteroscopic suction curettage appear to be nice options.However pituitrin injection combined with hysteroscopic suction curettage possesses an apparent advantage over uterine artery embolization(UAE)followed by suction curettage.It may be a priority option for Type ? cesarean scar pregnancy.